| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3416190 | Microbes and Infection | 2006 | 7 Pages |
Abstract
Lipopolysaccharide-binding protein (LBP) has a well-established role in Gram-negative infection. New data suggest a more expanded role for LBP as a general recognition molecule. Several bacterial surface components from Gram-positive pathogens are also recognized by this molecule. LBP may also serve as a clinical marker in severe infections and may carry therapeutic potential.
Keywords
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Janine Zweigner, Ralf R. Schumann, Joerg R. Weber,